D. J. Isaacs, N. Kathuria-Prakash, R. Hilder, M. G. Lechner, and A. Drakaki, “Risk of severe immune-related adverse events in cancer patients with pre-existing autoimmunity receiving immune checkpoint inhibitor therapy”, CCR, vol. 5, no. 1, pp. 168-180, Jan. 2024.